Literature DB >> 11720768

Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease.

M Sánchez-Guerra1, O Combarros, J Infante, J Llorca, J Berciano, A Fontalba, J L Fernández-Luna, N Peña, C Fernández-Viadero.   

Abstract

The low density lipoprotein receptor-related protein (LRP) may influence both the clearance and the production of beta-amyloid peptide and thus plays a role in Alzheimer's disease (AD) pathogenesis. Previous studies, although inconsistent, have suggested that the LRP exon 3 CC genotype contributes to the risk of AD. A case-control study utilizing a clinically well-defined group of 305 sporadic AD patients and 304 control subjects was performed to test this association in an ethnically homogeneous population from Spain. In the current study, the LRP CC genotype was not over-represented in AD patients compared to non-demented controls. A meta-analysis of previous studies revealed a weak correlation of LRP CC genotype with AD (odds ratio of 1.35, P=0.01).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720768     DOI: 10.1016/s0304-3940(01)02342-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Genetic interaction between two apolipoprotein E receptors increases Alzheimer's disease risk.

Authors:  Eloy Rodríguez; Ignacio Mateo; Javier Llorca; Coro Sánchez-Quintana; Jon Infante; José Berciano; Onofre Combarros
Journal:  J Neurol       Date:  2005-11-29       Impact factor: 4.849

Review 2.  LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.

Authors:  Anna P Lillis; Lauren B Van Duyn; Joanne E Murphy-Ullrich; Dudley K Strickland
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

3.  Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer's disease in a sample of Colombian patients.

Authors:  D A Forero; G Arboleda; J J Yunis; R Pardo; H Arboleda
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

4.  A pilot study of gene/gene and gene/environment interactions in Alzheimer disease.

Authors:  Nader Ghebranious; Bickol Mukesh; Philip F Giampietro; Ingrid Glurich; Susan F Mickel; Stephen C Waring; Catherine A McCarty
Journal:  Clin Med Res       Date:  2010-08-03

5.  Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.

Authors:  E Rodríguez; I Mateo; J Infante; J Llorca; J Berciano; O Combarros
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

6.  Association of Low-Density Lipoprotein Receptor-Related Protein 1 and Its rs1799986 Polymorphism With Mild Cognitive Impairment in Chinese Patients With Type 2 Diabetes.

Authors:  Wuyou Cao; Sai Tian; Haoqiang Zhang; Wenwen Zhu; Ke An; Jijing Shi; Yang Yuan; Shaohua Wang
Journal:  Front Neurosci       Date:  2020-09-11       Impact factor: 4.677

7.  Association between LRP1 C766T polymorphism and Alzheimer's disease susceptibility: a meta-analysis.

Authors:  Yun Wang; Shengyuan Liu; Jingjing Wang; Jie Zhang; Yaqiong Hua; Hua Li; Huibiao Tan; Bin Kuai; Biao Wang; Sitong Sheng
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

8.  Alzheimer's amyloid-β and tau protein accumulation is associated with decreased expression of the LDL receptor-associated protein in human brain tissue.

Authors:  Claire E Shepherd; Andrew J Affleck; Anita Y Bahar; Francine Carew-Jones; Gillian Gregory; David H Small; Glenda M Halliday
Journal:  Brain Behav       Date:  2020-06-02       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.